What is he best known for?
The fields of study he is best known for:
- Gene
- Enzyme
- Internal medicine
Ramiro Jover focuses on Molecular biology, Drug metabolism, Transcription factor, Internal medicine and Endocrinology.
His Molecular biology research integrates issues from Expression vector, Messenger RNA, Gene, Metallothionein and p38 mitogen-activated protein kinases.
His research in Drug metabolism intersects with topics in Drug development, Hepatocyte and Cell biology.
His study on Nuclear receptor and Transactivation is often connected to JAK-STAT signaling pathway as part of broader study in Transcription factor.
As part of his studies on Internal medicine, Ramiro Jover frequently links adjacent subjects like Gut flora.
His Endocrinology study combines topics in areas such as Serum amyloid A, Nonalcoholic fatty liver disease, Fatty liver and Immunology.
His most cited work include:
- Hepatogenic differentiation of human mesenchymal stem cells from adipose tissue in comparison with bone marrow mesenchymal stem cells (224 citations)
- Human hepatocytes in primary culture: the choice to investigate drug metabolism in man. (209 citations)
- Cytochrome P450 regulation by hepatocyte nuclear factor 4 in human hepatocytes: a study using adenovirus-mediated antisense targeting. (195 citations)
What are the main themes of his work throughout his whole career to date?
Ramiro Jover mainly investigates Internal medicine, Pharmacology, Endocrinology, Fatty liver and Molecular biology.
His work focuses on many connections between Internal medicine and other disciplines, such as Oncology, that overlap with his field of interest in Circulating MicroRNA, Serum microrna and Cohort.
Ramiro Jover interconnects Biochemistry, Toxicity and In vivo in the investigation of issues within Pharmacology.
His studies in Endocrinology integrate themes in fields like Calcitriol receptor and Transcriptional regulation.
His Fatty liver research incorporates themes from Steatosis, Gut flora and Lipid metabolism.
His work deals with themes such as Transcription factor, Hepatocyte nuclear factors, Messenger RNA, Cytochrome P450 and Isozyme, which intersect with Molecular biology.
He most often published in these fields:
- Internal medicine (36.52%)
- Pharmacology (32.17%)
- Endocrinology (30.43%)
What were the highlights of his more recent work (between 2016-2021)?
- Internal medicine (36.52%)
- Fatty liver (32.17%)
- Endocrinology (30.43%)
In recent papers he was focusing on the following fields of study:
His primary scientific interests are in Internal medicine, Fatty liver, Endocrinology, Gut flora and Steatosis.
Ramiro Jover studies Nonalcoholic fatty liver disease, a branch of Internal medicine.
His study focuses on the intersection of Fatty liver and fields such as Pharmacology with connections in the field of Microarray.
His Endocrinology research focuses on Calcitriol receptor and how it connects with Lithocholic acid, Intracellular and Hepatocyte.
His Steatosis study integrates concerns from other disciplines, such as Metabolic syndrome, Liver steatosis and Liver graft.
His Lipid metabolism research incorporates elements of Dysbiosis and Lipotoxicity.
Between 2016 and 2021, his most popular works were:
- Protective effect of quercetin on high-fat diet-induced non-alcoholic fatty liver disease in mice is mediated by modulating intestinal microbiota imbalance and related gut-liver axis activation (157 citations)
- Protective effect of quercetin on high-fat diet-induced non-alcoholic fatty liver disease in mice is mediated by modulating intestinal microbiota imbalance and related gut-liver axis activation (157 citations)
- Non-invasive prediction of NAFLD severity: a comprehensive, independent validation of previously postulated serum microRNA biomarkers (28 citations)
In his most recent research, the most cited papers focused on:
- Gene
- Enzyme
- Internal medicine
The scientist’s investigation covers issues in Fatty liver, Immunology, Gut flora, Internal medicine and Nonalcoholic fatty liver disease.
The concepts of his Fatty liver study are interwoven with issues in Steatosis and Metabolic syndrome.
The Steatosis study combines topics in areas such as Microarray, Cyclosporin a and Fenofibrate, Pharmacology.
His studies deal with areas such as Drug, Lipid metabolism, Dysbiosis and Lipotoxicity as well as Metabolic syndrome.
His Internal medicine study combines topics in areas such as Serum microrna, microRNA and Circulating MicroRNA.
His Nonalcoholic fatty liver disease research incorporates elements of Liver injury and Oncology.
This overview was generated by a machine learning system which analysed the scientist’s
body of work. If you have any feedback, you can
contact us
here.
